Kinsalic Ointment is a topical formulation containing Clobetasol propionate (0.05% w/w) and Salicylic Acid (3.0% w/w), designed for the management of various dermatological conditions. Clobetasol propionate is a potent corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive effects, effectively reducing inflammation and immune responses in affected skin areas. Salicylic Acid, a keratolytic agent, facilitates the softening and removal of hyperkeratotic scales by promoting exfoliation of the stratum corneum, thereby enhancing the penetration and efficacy of the corticosteroid component. Kinsalic Ointment is primarily indicated for the treatment of psoriasis, eczema, seborrheic dermatitis, and other hyperkeratotic skin disorders where inflammation and scaling are prominent. The combination therapy provides rapid symptomatic relief by controlling erythema, itching, and scaling. It is recommended for topical application in thin layers to the affected areas, avoiding prolonged use or application on large body surfaces to minimize potential systemic absorption and adverse effects. Use under medical supervision is advised, particularly in pediatric, pregnant, or lactating patients. Common side effects may include local irritation, dryness, or burning sensation. Discontinuation should be gradual to prevent rebound symptoms.